Sharp upturn of life expectancy in the Netherlands: Effect of increased health care for the elderly;Snelle toename van de levensverwachting in Nederland

Nederlands Tijdschrift voor Geneeskunde

Volumn 156, Issue 9, 2012, Pages

  Mackenbach, Johan P ^a   Slobbe, Lany ^b   Looman, Caspar W N ^a   Van Der Heide, Agnes ^a   Polder, Johan ^b   Garssen, Joop ^c,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c TILBURG UNIVERSITY   (Netherlands)

^d STATISTICS NETHERLANDS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ELDERLY CARE; HEALTH CARE; LIFE EXPECTANCY; NETHERLANDS;

EID: 84873364714     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Oeppen J, Vaupel JW. Broken limits to life expectancy. Science. 2002;296:1029-31.
2. Hoogendoorn D. Indrukwekkende en tegelijk teleurstellende daling van de perinatale sterfte in Nederland. Ned Tijdschr Geneeskd. 1986;130:1436-40.
3. Mackenbach J P. Perinatale sterfte in Nederland: een probleem van velen, een probleem van niemand. Ned Tijdschr Geneeskd. 2006;150:409-11.
4. Nusselder WJ, Mackenbach J P. Rectangularization of the survival curve in the Netherlands, 1950-1992. Gerontologist. 1996;36:773-82.
5. Nusselder WJ, Mackenbach J P. Rectangularization of the survival curve in the Netherlands: an analysis of underlying causes of death. J Gerontol: Soc Sci. 1997;52:S145-54.
6. Nusselder WJ, Mackenbach J P. Lack of improvement of life expectancy at advanced ages in The Netherlands. Int J Epidemiol. 2000;29:140-8.
7. Janssen F, Nusselder WJ, Looman C W N, Mackenbach JP, Kunst AE. Stagnation in mortality decline among elders in the Netherlands. Gerontologist. 2003;43:722-34.
8. Janssen F, Mackenbach J P, Kunst AE. Trends in old-age mortality in seven European countries, 1950-1999. J Clin Epidemiol. 2004;57:203-16.
9. Meslé F, Vallin J. Diverging trends in female old-age mortality: the United States and the Netherlands versus France and Japan. Pop Dev Rev. 2006;31:123-45.
10. Juel K, Bjerregaard P, Madsen M. Mortality and life expectancy in Denmark and other European countries. What is happening to middleaged Danes? Eur J Publ Health. 2000;10:93-100.
11. McKeown ThF. The role of medicine: dream, mirage or nemesis. London: Nuffield Provincial Hospitals Trust; 1976.
12. Szreter S. The importance of social interventions in Britain's mortality decline c. 1850-1914: a re-interpretation of the role of public health. Soc Hist Med. 1988;1:5-37.
13. Mackenbach J P. The contribution of medical care to mortality decline: McKeown revisited. J Clin Epidemiol. 1996;49:1207-13.
14. Mackenbach JP, Looman C W N. Secular trends of infectious disease mortality in the Netherland, 1911-1978: quantitative estimates of changes coinciding with the introduction of antibiotics. Int J Epidemiol. 1988;17:618-24.
15. Bunker JP, Frazier HS, Mosteller F. Improving health: measuring efects of medical care. Milbank Quarterly. 1994;72:225-58.
16. Cutler DM, Rosen AB, Vijan S. The value of medical spending in the United States, 1960-2000. N Engl J Med. 2006;355:920-27.
17. Clayton D, Schifflers E. Models for temporal variation in cancer rates. I: Age-Period and Age-Cohort models. Stat Med. 1987;6:449-67.
18. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II: Age-Period-Cohort models. Stat Med. 1987;6:469-81.
19. Slobbe L C J, Kommer GJ, Smit JM, Groen J, Meerding WJ, Polder JJ. Kosten van ziekten in Nederland 2003. Zorg voor euro's-1. RIVM-report nr. 270751010. Bilthoven: RIVM; 2006.
20. Van Der Heide A, Onwuteaka-Philipsen B, Rurup ML, Buiting HM, Van Delden J J M, Hanssen-De Wolff JE, et al. End-of-life practices in the Netherlands under the Euthanasia Act. N Engl J Med. 2007;356:1957-65.
21. Verweij G, De Bruin A. Flinke daling sterfte na opname voor beroerte en prostaatkanker. Statistics Netherlands Webmagazine, 2008;31 maart.
22. Exel N J A van, Koopmanschap MA, Scholte Op Reimer W, Niessen LW, Huijsman R. Cost-effectiveness of integrated stroke services. QJM. 2005;98:415-25.
23. Slaets J. 'The old man's friend': verschillen in besluitvorming over behandeling van pneumonie bij demente verpleeghuispatiënten in Nederland en de Verenigde Staten. Ned Tijdschr Geneeskd. 2007;151:905-6.
24. Van Der Meulen A, Keij-Deerenberg I. Sterfte aan dementie. Bevolkingstrends. 2003;51:24-8.
25. Van Der Heide A, Deliens L, Faisst K, Nilstun T, Norup M, et al. End-oflife decision-making in six European countries: descriptive study. Lancet. 2004;362:345-50.
26. Löfmark R, Nilston T, Cartwright C, Fischer S, Van Der Heide A, Mortier F, et al. Physicians' experiences with end-of-life decision-making: Survey in 6 European countries and Australia. BMC Med. 2008;6:4.
27. Janssen F, Van Der Heide A, Kunst AE, Mackenbach J P. End-of-life decisions and old-age mortality: a cross-country analysis (Letter). J Am Geriatr Soc. 2006;54:1951-3.
28. Mehta JL, Bursac Z, Hauer-Jensen M, Fort C, Fink LM. Comparison of mortality rates in statin users versus nonstatin users in a United States veteran population. Am J Cardiol. 2006;98:923-8.
29. Perry HM, Davis BR, Price TR, Applegate WB, Fields WS, Guralnick JM, et al. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 2000;284:465-71.
30. Richtlijn Cardiovasculair Risicomanagement. Utrecht: NIV; 2004
31. Polder JJ. De zorguitgaven als Januskop - trends in getallen en gezichtspunten. In: Mackenbach JP. Trends in volksgezondheid en gezondheidszorg. Maarssen: Elsevier; 2009.
32. Huber M, Orosz E. Health expenditure trends in OECD countries, 1990-2001. Health Care Financing Review. 2003;25:1-22.
33. Kamerstukken: Actieplan Zorg Verzekerd. Kamerstukken 2000-2001, 27. 488 nr. 1.